ADM’s spore-forming DE111 probiotic approved by China’s National Health Commission
ADM has announced that its spore-forming probiotic called DE111 has been approved by China’s National Health Commission.
Photo © AdobeStock.com/picture-waterfall
ADM has announced that its spore-forming probiotic called DE111 (Bacillus subtilis) has been approved by China’s National Health Commission (NHC).
“ADM is committed to providing innovative functional ingredients and solutions that meet the highest regulatory standards and which meet the legislative criteria in China, and worldwide,” said Helen Hu, president of health & wellness APAC at ADM, in a press release. “The approval process required by governmental authorities are rigorous and thorough, and this achievement is a significant milestone in our market development. ADM is the first and only provider of the Bacillus subtilis food ingredient to the Chinese market.”
“China is projecting substantial growth opportunities for biotics,” added Hu. “This is in part due to the country’s drive towards innovation, in addition to its strong population, economy, and history of focusing on preventative wellness solutions. With the approval of DE111, we can empower individuals across the globe to proactively manage their wellness goals with our science-backed gut health microbiome-supporting solutions.”
DE111 is clinically substantiated. It has been shown in research to survive the stomach and germinate the human gastrointestinal tract, and carries published health claims in some jurisdictions for the supporting the growth of beneficial bacteria and improving digestive health in adults and children. As a spore-forming probiotic, the ingredient also retains functionality throughout challenging processing conditions.
DE111 was added to ADM’s portfolio when the company acquired Deerland Probiotics and Enzymes in 2021.
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
